RxDoctor Payments Data

Michael Block, DO

Geriatric Medicine · Delray Beach, FLNPI 1942385919

Payments from drug & device makers

$514in general payments, 2019–2025

Across 23 payments — averaging $22.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mylan Specialty L.p.$240
  • Novartis$74
  • Otsuka America Pharmaceutical, Inc.$74
  • Neurocrine Biosciences, Inc.$43
  • Lundbeck LLC$27
  • Sumitomo Pharma America, Inc.$22
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$514100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$514 in reported general payments places this provider in the 60th percentile of 305 geriatric medicine providers in Florida.

See all geriatric medicine providers in Florida

Medicare billing

Part B allowed, 2024
$277,986
Medicare patients
232
Services billed
2,772

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban132$77,690
MounjaroTirzepatide65$69,100
XifaxanRifaximin12$41,256
XareltoRivaroxaban32$26,740
OzempicSemaglutide17$18,533
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr26$12,239
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog27$10,144
MyrbetriqMirabegron12$5,301
Atorvastatin Calcium307$4,439
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$3,569
Rosuvastatin Calcium166$3,359
Brimonidine Tartrate20$3,309
Tamsulosin Hcl131$3,100
Levothyroxine Sodium207$2,780
Clonazepam104$2,674

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$14$69,10065 claims
Astellas Pharma US IncMyrbetriq$20$5,30112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 305 geriatric medicine providers in Florida.

Other geriatric medicine in Delray Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →